BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
10/31/2024 8:01:11 AM | Browse: 23 | Download: 70
 |
Received |
|
2024-08-22 18:12 |
|
Peer-Review Started |
|
2024-08-22 18:12 |
 |
To Make the First Decision |
|
|
|
Return for Revision |
|
2024-09-17 06:00 |
|
Revised |
|
2024-09-21 07:50 |
|
Second Decision |
|
2024-10-18 01:32 |
|
Accepted by Journal Editor-in-Chief |
|
|
|
Accepted by Executive Editor-in-Chief |
|
2024-10-20 10:16 |
|
Articles in Press |
|
2024-10-20 10:16 |
|
Publication Fee Transferred |
|
|
|
Edit the Manuscript by Language Editor |
|
|
|
Typeset the Manuscript |
|
2024-10-28 06:01 |
|
Publish the Manuscript Online |
|
2024-10-31 08:01 |
| ISSN |
1949-8462 (online) |
| Open Access |
This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: https://creativecommons.org/licenses/by-nc/4.0/ |
| Copyright |
© The Author(s) 2024. Published by Baishideng Publishing Group Inc. All rights reserved. |
| Article Reprints |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
|
| Permissions |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
|
| Publisher |
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA |
| Website |
http://www.wjgnet.com |
| Category |
Cardiac & Cardiovascular Systems |
| Manuscript Type |
Editorial |
| Article Title |
Living biodrugs and how tissue source influences mesenchymal stem cell therapeutics for heart failure
|
| Manuscript Source |
Invited Manuscript |
| All Author List |
Siddharth Shah, Huzaifa Sabir Nawaz, Muhammad Saeed Qazi, Hritvik Jain and Brandon Lucke-Wold |
| ORCID |
|
| Funding Agency and Grant Number |
|
| Corresponding Author |
Siddharth Shah, Postdoctoral Fellow, Lillian S Wells Department of Neurosurgery, University of Florida, 1505 SW Archer Road, Gainesville, FL 32608, United States. siddharth.dr99@gmail.com |
| Key Words |
Mesenchymal stem cells; Heart failure; Umbilical cord-derived mesenchymal stem cells; Bone marrow-derived mesenchymal stem cells; Therapeutics for heart failure; Biodrugs; Tissue source |
| Core Tip |
Mesenchymal stem cells (MSCs) offer a novel regenerative approach to treating heart failure (HF), especially ischemic HF, by modulating inflammation, reducing fibrosis, and promoting tissue repair. Sources like bone marrow and umbilical cord each provide distinct benefits. Umbilical cord-derived MSCs are particularly promising due to their superior growth capacity and reduced senescence. However, challenges in cell retention and delivery persist. Current research focuses on refining MSC sources, enhancing differentiation, and improving delivery methods, paving the way for MSCs to become a pivotal therapy in HF management. |
| Publish Date |
2024-10-31 08:01 |
| Citation |
<p>Shah S, Nawaz HS, Qazi MS, Jain H, Lucke-Wold B. Living biodrugs and how tissue source influences mesenchymal stem cell therapeutics for heart failure. <i>World J Cardiol</i> 2024; 16(11): 619-625</p> |
| URL |
https://www.wjgnet.com/1949-8462/full/v16/i11/619.htm |
| DOI |
https://dx.doi.org/10.4330/wjc.v16.i11.619 |
© 2004-2025 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
California Corporate Number: 3537345
